Cerity Partners LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1566475 NEW YORK, NY

Position in MRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,328,235

-$192,488 QoQ

Shares Held

469,341

+0.3% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 99.55895606818923.ToString("F0")% Shared 0.ToString("F0")% None 0.44104393181077295.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $355,132,750 across 115 Biotechnology names. MRVI ranks #24 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	296,654	$132,467,876
2	REGN	Regeneron Pharmaceuticals, Inc.	43,972	$33,974,525
3	CORT	Corcept Therapeutics Inc	731,689	$29,494,383
4	HALO	Halozyme Therapeutics, Inc.	349,137	$22,564,723
5	INCY	Incyte Corp	226,501	$21,318,272
6	BMRN	Biomarin Pharmaceutical Inc	263,389	$14,878,843
7	EXEL	Exelixis, Inc.	313,945	$13,465,100
8	JAZZ	Jazz Pharmaceuticals plc	45,746	$8,648,280

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,328,235	469,341	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$1,520,723	467,915	+3898.6%	Shares	Sole	2026-02-11
2024-09-30	$97,243	11,702	-16.0%	Shares	Sole	2024-11-12
2024-03-31	$120,842	13,938	-34.4%	Shares	Sole	2024-05-14
2022-09-30	$542,231	21,239	-18.7%	Shares	Sole	2022-11-14
2022-06-30	$742,552	26,137	+8.5%	Shares	Sole	2022-08-10
2022-03-31	$849,372	24,082	+60.5%	Shares	Sole	2022-04-25
2021-03-31	$534,600	15,000	-0.4%	Shares	Sole	2021-08-11
2020-12-31	$422,348	15,057	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.